Pharmaceutical commercial stocks are repeatedly active, NEPTUNUS has a 6-day consecutive limit-up, Realcan hits the limit-up, HRPC, SHKK, INT'L GROUP, and others follow suit. In news, China's drug price registration system has officially launched

The three major A-share indices opened lower collectively, with SDSL falling over 7%

36Kr learned that the three major A-share indices opened lower collectively, with the Shanghai Composite Index down 0.05%, the Shenzhen Component Index down 0.07%, and the ChiNext Index down 0.13%; the gas, trade, and real estate sectors saw the largest declines, with HRPC hitting the limit down, SDSL dropping over 7%, and Huaxia Happiness falling over 6%; the office supplies, precious metals, and shipping sectors led the gains, with Qixin Group hitting the limit up, China Merchants Energy rising over 2%, and Hunan Gold increasing over 1%

The A-shares opened lower, with the ChiNext down 0.43%. Computing hardware led the decline, while pharmaceutical stocks collectively surged. The Hong Kong stocks opened higher, continuing the upward trend in new consumption

A-shares opened lower, with the Shanghai Composite Index down 0.15% and the ChiNext down 0.43%. Sectors such as computing hardware, photovoltaics, and lithium batteries performed poorly, while pharmaceutical stocks rose collectively. Hong Kong stocks opened higher, with the Hang Seng Index up 0.22%, and new consumption concept stocks continued to strengthen. Most of the bond market rose, commodity prices fluctuated, and the main crude oil contract rose by more than 2%

HRPC released its performance for the first three quarters, with a net profit attributable to shareholders of 112 million yuan, a year-on-year decrease of 45.69%

HRPC released its Q3 2025 performance, with revenue of 7.846 billion yuan in the first three quarters, a year-on-year increase of 2.19%; net profit attributable to shareholders of 112 million yuan, a year-on-year decrease of 45.69%; net profit excluding non-recurring items of 110 million yuan, a year-on-year decrease of 42.68%; basic earnings per share of 0.1929 yuan. The decline in net profit is mainly due to the decrease in gross profit, changes in operating-related expenses, and an increase in the provision for bad debts of accounts receivable

HRPC released its performance for the first half of the year, with a net profit attributable to the parent company of 72.5792 million yuan, a decrease of 46.31%

HRPC released its semi-annual report for 2025, with operating revenue of 479 million yuan, a year-on-year decrease of 90.39%. The net profit attributable to shareholders was 72.5792 million yuan, a year-on-year decline of 46.31%. The net profit after deducting non-recurring gains and losses was 72.4414 million yuan, a year-on-year decrease of 41.20%. The basic earnings per share were 0.1252 yuan. The decline in net profit was mainly due to a decrease in gross profit, changes in sales, and an increase in the provision for bad debts of accounts receivable